RARB and acute promyelocytic leukemia: Although ATRA is capable of inducing APL cells into a differentiated granulocytic phenotype, most evidence suggest that target genes, including differentiation-inducing gene TGM2 and canonical target gene RARβ, remain aberrantly hypermethylated upon ATRA treatment14,45.